CFDA:16批次药品抽检不合格

2017-09-29 佚名 赛柏蓝

9月28日,国家食药监总局发布《关于16批次药品不合格的通告(2017年第156号)》。


9月28日,国家食药监总局发布《关于16批次药品不合格的通告(2017年第156号)》。

标示为甘肃天森药业有限公司等10家企业生产的16批次药品不合格。(详见附件)

对于不合格药品,总局在通告中说明,相关省级食药监局已采取查封扣押等控制措施,要求企业暂停销售使用、召回产品,并进行整改。

总局要求相关监管部门,对生产销售不合格药品的违法行为进行立案调查,三个月内公开对生产销售不合格药品相关企业或单位的处理结果,相关情况及时报告总局。

附:16批次不合格药品名单

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1782861, encodeId=01e01e8286195, content=<a href='/topic/show?id=a06c45212a' target=_blank style='color:#2F92EE;'>#CFDA:#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4521, encryptionId=a06c45212a, topicName=CFDA:)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Nov 24 09:52:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668941, encodeId=5c44166894190, content=<a href='/topic/show?id=1086203266c' target=_blank style='color:#2F92EE;'>#不合格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20326, encryptionId=1086203266c, topicName=不合格)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77c26479803, createdName=echonoir, createdTime=Wed Feb 28 11:52:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890659, encodeId=4ea7189065917, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4520, encryptionId=a867452008, topicName=CFDA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sun Aug 12 07:52:00 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2017-11-24 doctorzheng
  2. [GetPortalCommentsPageByObjectIdResponse(id=1782861, encodeId=01e01e8286195, content=<a href='/topic/show?id=a06c45212a' target=_blank style='color:#2F92EE;'>#CFDA:#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4521, encryptionId=a06c45212a, topicName=CFDA:)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Nov 24 09:52:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668941, encodeId=5c44166894190, content=<a href='/topic/show?id=1086203266c' target=_blank style='color:#2F92EE;'>#不合格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20326, encryptionId=1086203266c, topicName=不合格)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77c26479803, createdName=echonoir, createdTime=Wed Feb 28 11:52:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890659, encodeId=4ea7189065917, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4520, encryptionId=a867452008, topicName=CFDA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sun Aug 12 07:52:00 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1782861, encodeId=01e01e8286195, content=<a href='/topic/show?id=a06c45212a' target=_blank style='color:#2F92EE;'>#CFDA:#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4521, encryptionId=a06c45212a, topicName=CFDA:)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Nov 24 09:52:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668941, encodeId=5c44166894190, content=<a href='/topic/show?id=1086203266c' target=_blank style='color:#2F92EE;'>#不合格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20326, encryptionId=1086203266c, topicName=不合格)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f77c26479803, createdName=echonoir, createdTime=Wed Feb 28 11:52:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890659, encodeId=4ea7189065917, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4520, encryptionId=a867452008, topicName=CFDA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sun Aug 12 07:52:00 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2018-08-12 stfoxst